These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 21450822)

  • 1. Oncolytic vesicular stomatitis virus induces apoptosis in U87 glioblastoma cells by a type II death receptor mechanism and induces cell death and tumor clearance in vivo.
    Cary ZD; Willingham MC; Lyles DS
    J Virol; 2011 Jun; 85(12):5708-17. PubMed ID: 21450822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variation in susceptibility of human malignant melanomas to oncolytic vesicular stomatitis virus.
    Blackham AU; Northrup SA; Willingham M; D'Agostino RB; Lyles DS; Stewart JH
    Surgery; 2013 Mar; 153(3):333-43. PubMed ID: 23102637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular determinants of susceptibility to oncolytic vesicular stomatitis virus in pancreatic adenocarcinoma.
    Blackham AU; Northrup SA; Willingham M; Sirintrapun J; Russell GB; Lyles DS; Stewart JH
    J Surg Res; 2014 Apr; 187(2):412-26. PubMed ID: 24252853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vesicular stomatitis viruses expressing wild-type or mutant M proteins activate apoptosis through distinct pathways.
    Gaddy DF; Lyles DS
    J Virol; 2005 Apr; 79(7):4170-9. PubMed ID: 15767418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune Effects of M51R Vesicular Stomatitis Virus Treatment of Carcinomatosis From Colon Cancer.
    Day GL; Bryan ML; Northrup SA; Lyles DS; Westcott MM; Stewart JH
    J Surg Res; 2020 Jan; 245():127-135. PubMed ID: 31415934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. M51R and Delta-M51 matrix protein of the vesicular stomatitis virus induce apoptosis in colorectal cancer cells.
    Gray Z; Tabarraei A; Moradi A; Kalani MR
    Mol Biol Rep; 2019 Jun; 46(3):3371-3379. PubMed ID: 31006094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triptolide-mediated inhibition of interferon signaling enhances vesicular stomatitis virus-based oncolysis.
    Ben Yebdri F; Van Grevenynghe J; Tang VA; Goulet ML; Wu JH; Stojdl DF; Hiscott J; Lin R
    Mol Ther; 2013 Nov; 21(11):2043-53. PubMed ID: 23985699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncolytic measles and vesicular stomatitis virotherapy for endometrial cancer.
    Liu YP; Steele MB; Suksanpaisan L; Federspiel MJ; Russell SJ; Peng KW; Bakkum-Gamez JN
    Gynecol Oncol; 2014 Jan; 132(1):194-202. PubMed ID: 24246772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in the glycoprotein of vesicular stomatitis virus affect cytopathogenicity: potential for oncolytic virotherapy.
    Janelle V; Brassard F; Lapierre P; Lamarre A; Poliquin L
    J Virol; 2011 Jul; 85(13):6513-20. PubMed ID: 21561919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncolytic vesicular stomatitis virus as a treatment for neuroendocrine tumors.
    Randle RW; Northrup SA; Sirintrapun SJ; Lyles DS; Stewart JH
    Surgery; 2013 Dec; 154(6):1323-29; discussion 1329-30. PubMed ID: 23973113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of apoptosis in pancreatic cancer cells by vesicular stomatitis virus.
    Felt SA; Moerdyk-Schauwecker MJ; Grdzelishvili VZ
    Virology; 2015 Jan; 474():163-73. PubMed ID: 25463614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensitivity of prostate tumors to wild type and M protein mutant vesicular stomatitis viruses.
    Ahmed M; Cramer SD; Lyles DS
    Virology; 2004 Dec; 330(1):34-49. PubMed ID: 15527832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VSV virotherapy improves chemotherapy by triggering apoptosis due to proteasomal degradation of Mcl-1.
    Schache P; Gürlevik E; Strüver N; Woller N; Malek N; Zender L; Manns M; Wirth T; Kühnel F; Kubicka S
    Gene Ther; 2009 Jul; 16(7):849-61. PubMed ID: 19369968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic therapy of experimental breast cancer metastases by mutant vesicular stomatitis virus in immune-competent mice.
    Ebert O; Harbaran S; Shinozaki K; Woo SL
    Cancer Gene Ther; 2005 Apr; 12(4):350-8. PubMed ID: 15565179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Curcumin promotes the oncoltyic capacity of vesicular stomatitis virus for the treatment of prostate cancers.
    Fehl DJ; Ahmed M
    Virus Res; 2017 Jan; 228():14-23. PubMed ID: 27865863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination of measles virus virotherapy and radiation therapy has synergistic activity in the treatment of glioblastoma multiforme.
    Liu C; Sarkaria JN; Petell CA; Paraskevakou G; Zollman PJ; Schroeder M; Carlson B; Decker PA; Wu W; James CD; Russell SJ; Galanis E
    Clin Cancer Res; 2007 Dec; 13(23):7155-65. PubMed ID: 18056196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Semireplication-competent vesicular stomatitis virus as a novel platform for oncolytic virotherapy.
    Muik A; Dold C; Geiß Y; Volk A; Werbizki M; Dietrich U; von Laer D
    J Mol Med (Berl); 2012 Aug; 90(8):959-70. PubMed ID: 22286341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting the apoptotic pathway with BCL-2 inhibitors sensitizes primary chronic lymphocytic leukemia cells to vesicular stomatitis virus-induced oncolysis.
    Tumilasci VF; Olière S; Nguyên TL; Shamy A; Bell J; Hiscott J
    J Virol; 2008 Sep; 82(17):8487-99. PubMed ID: 18579592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vesicular stomatitis virus expressing interferon-β is oncolytic and promotes antitumor immune responses in a syngeneic murine model of non-small cell lung cancer.
    Patel MR; Jacobson BA; Ji Y; Drees J; Tang S; Xiong K; Wang H; Prigge JE; Dash AS; Kratzke AK; Mesev E; Etchison R; Federspiel MJ; Russell SJ; Kratzke RA
    Oncotarget; 2015 Oct; 6(32):33165-77. PubMed ID: 26431376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell Death Mechanisms in Esophageal Squamous Cell Carcinoma Induced by Vesicular Stomatitis Virus Matrix Protein.
    Douzandegan Y; Tahamtan A; Gray Z; Nikoo HR; Tabarraei A; Moradi A
    Osong Public Health Res Perspect; 2019 Aug; 10(4):246-252. PubMed ID: 31497497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.